This topic contains a solution. Click here to go to the answer

Author Question: A patient is taking a xanthine derivative as part of treatment for chronic obstructive pulmonary ... (Read 101 times)

magmichele12

  • Hero Member
  • *****
  • Posts: 559
A patient is taking a xanthine derivative as part of treatment for chronic obstructive pulmonary disease. The nurse will monitor for which adverse effects associated with the use of xanthine derivatives?
 
  a. Diarrhea
  b. Palpitations
  c. Bradycardia
  d. Drowsiness

Question 2

After receiving a nebulizer treatment with a beta agonist,
 
  the patient complains of feeling slightly nervous and wonders if her asthma is getting worse. What is the nurse's best response?
  a. This is an expected adverse effect. Let me take your pulse.
  b. The next scheduled nebulizer treatment will be skipped.
  c. I will notify the physician about this adverse effect.
  d. We will hold the treatment for 24 hours.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

cam1229

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

ANS: B

Answer to Question 2

ANS: A




magmichele12

  • Member
  • Posts: 559
Reply 2 on: Jul 23, 2018
Wow, this really help


EAN94

  • Member
  • Posts: 307
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The most common treatment options for addiction include psychotherapy, support groups, and individual counseling.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Thyroid conditions cause a higher risk of fibromyalgia and chronic fatigue syndrome.

Did you know?

Sildenafil (Viagra®) has two actions that may be of consequence in patients with heart disease. It can lower the blood pressure, and it can interact with nitrates. It should never be used in patients who are taking nitrates.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

For a complete list of videos, visit our video library